Monte Rosa Therapeutics, Inc. (GLUE) — SC 13G/A Filings
All SC 13G/A filings from Monte Rosa Therapeutics, Inc.. Browse 8 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (8)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Apr 10, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
-
FMR LLC Discloses 11.056% Stake in Monte Rosa Therapeutics
— Feb 9, 2024 Risk: low
FMR LLC, a major investment management firm, and its Chair and CEO, Abigail P. Johnson, have filed an amended SC 13G/A for Monte Rosa Therapeutics, Inc. (MRTX).
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX